|
1
|
D'Amico G: Natural history of idiopathic
IgA nephropathy and factors predictive of disease outcome. Semin
Nephrol. 24:179–196. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barratt J, Feehally J and Smith AC:
Pathogenesis of IgA nephropathy. Semin Nephrol. 24:197–217. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tarelli E, Smith AC, Hendry BM,
Challacombe SJ and Pouria S: Human serum IgA1 is substituted with
up to six O-glycans as shown by matrix assisted laser desorption
ionisation time-of-flight mass spectrometry. Carbohydr Res.
339:2329–2335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Renfrow MB, Cooper HJ, Tomana M, Kulhavy
R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG and Novak J:
Determination of aberrant O-glycosylation in the IgA1 hinge region
by electron capture dissociation Fourier transform-ion cyclotron
resonance mass spectrometry. J Biol Chem. 280:19136–19145. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M,
Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC,
et al: Patients with IgA nephropathy have increased serum
galactose-deficient IgA1 levels. Kidney Int. 71:1148–1154. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kokubo T, Hiki Y, Iwase H, Horii A, Tanaka
A, Nishikido J, Hotta K and Kobayashi Y: Evidence for involvement
of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA
nephropathy. J Am Soc Nephrol. 8:915–919. 1997.PubMed/NCBI
|
|
7
|
Yan Y, Xu LX, Zhang JJ, Zhang Y and Zhao
MH: Self-aggregated deglycosylated IgA1 with or without IgG were
associated with the development of IgA nephropathy. Clin Exp
Immunol. 144:17–24. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barratt J, Smith AC and Feehally J: The
pathogenic role of IgA1 O-linked glycosylation in the pathogenesis
of IgA nephropathy. Nephrology. 12:275–284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Floege J: The pathogenesis of IgA
nephropathy: What is new and how does it change therapeutic
approaches? Am J Kidney Dis. 58:992–1004. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ju T, Brewer K, D'Souza A, Cummings RD and
Canfield WM: Cloning and expression of human core 1
beta1,3-galactosyltransferase. J Biol Chem. 277:178–186. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ju T and Cummings RD: A unique molecular
chaperone Cosmc required for activity of the mammalian core 1 beta
3-galactosyltransferase. Proc Natl Acad Sci USA. 99:16613–16618.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Allen AC, Topham PS, Harper SJ and
Feehally J: Leucocyte beta 1,3 galactosyltransferase activity in
IgA nephropathy. Nephrol Dial Transplant. 12:701–706. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suzuki H, Moldoveanu Z, Hall S, Brown R,
Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JC, et al:
IgA1-secreting cell lines from patients with IgA nephropathy
produce aberrantly glycosylated IgA1. J Clin Invest. 118:629–639.
2008.PubMed/NCBI
|
|
14
|
Takahashi K, Raska M, Horynova M
Stuchlova, Hall SD, Poulsen K, Kilian M, Hiki Y, Yuzawa Y,
Moldoveanu Z, Julian BA, et al: Enzymatic sialylation of IgA1
O-Glycans: Implications for studies of IgA nephropathy. PLoS One.
9:e990262014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nagasawa R, Maruyama N, Imasawa T and
Mitarai T: Role of T cells in murine IgA nephropathy. Nephrol Dial
Transplant. 14 Suppl 1:S12–S13. 1999. View Article : Google Scholar
|
|
16
|
Lycke N: T cell and cytokine regulation of
the IgA response. Chem Immunol. 71:209–234. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chintalacharuvu SR and Emancipator SN: The
glycosylation of IgA produced by murine B cells is altered by Th2
cytokines. J Immunol. 159:2327–2333. 1997.PubMed/NCBI
|
|
18
|
Yamada K, Kobayashi N, Ikeda T, Suzuki Y,
Tsuge T, Horikoshi S, Emancipator SN and Tomino Y: Down-regulation
of core 1 beta 1,3-galactosyltransferase and Cosmc by Th2 cytokine
alters O-glycosylation of IgA1. Nephrol Dial Transplant.
25:3890–3897. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Suzuki H, Raska M, Yamada K, Moldoveanu Z,
Julian BA, Wyatt RJ, Tomino Y, Gharavi AG and Novak J: Cytokines
Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and
ST6GalNAc-II Enzymes. J Biol Chem. 289:5330–5339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu HH, Chu KH, Yang YH, Lee JH, Wang LC,
Lin YT and Chiang BL: Genetics and Immunopathogenesis of IgA
Nephropathy. Clinic Rev Allerg Immunol. 41:198–213. 2011.
View Article : Google Scholar
|
|
21
|
Toyabe S, Harada W and Uchiyama M:
Oligoclonally expanding gammadelta T lymphocytes induce IgA
switching in IgA nephropathy. Clin Exp Immunol. 124:110–117. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meng H, Zhang L, E XQ, Ye F, Li H, Han C,
Yamakawa M and Jin X: Application of Oxford classification, and
overexpression of transforming growth factor-β1 and immunoglobulins
in immunoglobulin A nephropathy: Correlation with World Health
Organization classification of immunoglobulin A nephropathy in a
Chinese patient cohort. Transl Res. 163:8–18. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang YH, Huang MT, Lin SC, Lin YT, Tsai MJ
and Chiang BL: Increased transfroming growth factor-beta
(TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody
levels during acute stage of childhood Henoch-Schönlein purpura.
Clin Exp Immunol. 122:285–290. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao J, Cao CY, Zhou J and Wang WH:
Changes in levels of Th1, Th2 and Th3 cells in peripheral blood in
patients with IgA nephropathy and their significance. Prac Clin
Med. 13:28–31. 2012.(In Chinese).
|
|
25
|
Qin W, Zhou Q, Yang LC, Li Z, Su BH, Luo H
and Fan JM: Peripheral B lymphocyte beta1, 3-galactosyltransferase
and chaperone expression in immunoglobulin A nephropathy. J Intern
Med. 258:467–477. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xie LS, Qin W, Fan JM, Huang J, Xie XS and
Li Z: The role of C1GALT1C1 in lipopolysaccharide-induced IgA1
aberrant O-glycosylation in IgA nephropathy. Clin Invest Med.
33:E5–E13. 2010.PubMed/NCBI
|
|
27
|
De Wolff JF, Dickinson SJ, Smith AC,
Molyneux K, Feehally J, Simon A and Barratt J: Abnormal IgD and
IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic
fever syndrome. Clin Exp Med. 9:291–296. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Prud'homme GJ and Piccirillo CA: The
inhibitory effects of transforming growth factor-beta-1(TGF-beta1)
in autoimmune diseases. J Autoimmun. 14:23–42. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Del Prete D, Gambaro G, Lupo A, Anglani F,
Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P,
et al: Precocious activation of genes of the renin-angiotensin
system and the fibrogenic cascade in IgA glomerulonephritis. Kidney
Int. 64:149–159. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leung JC, Chan LY, Tsang AW, Liu EW, Lam
MF, Tang SC and Lai KN: Anti-macrophagemigration inhibitory factor
reduces transforming growth factor-beta 1 expression in
experimental IgA nephropathy. Nephrol Dial Transplant.
19:1976–1985. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhong Q, Leung JC, Chan LY, Tsang AW, Chen
X and Lai KN: The study of Chinese medicinal herbal formula Shen
San Fang in the treatment of experimental IgA nephropathy. Am J
Chin Med. 33:613–626. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chihara Y, Ono H, Ishimitsu T, Ono Y,
Ishikawa K, Rakugi H, Ogihara T and Matsuoka H: Roles of TGF-beta 1
and apoptosis in the progression of glomerulosclerosis in human IgA
nephropathy. Clin Nephrol. 65:385–392. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim PH and Kagnoff MF: Transforming growth
factor beta 1 increases IgA isotype switching at the clonal level.
J Immunol. 145:3773–3778. 1990.PubMed/NCBI
|
|
35
|
Cazac BB and Roes J: TGF-beta receptor
controls B cell responsiveness and induction of IgA in vivo.
Immunity. 13:443–451. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boratyńska M: Urine excretion of
transforming growth factor-beta 1 in chronic allograft nephropathy.
Ann Transplant. 4:23–28. 1999.
|
|
37
|
Ibelgaufts H: Cytokines and Cells Online
Pathfinder Encyclopaedia (COPE). http://www.copewithcytokines.de/cope.cgi2007.
|
|
38
|
Kajdaniuk D, Marek B, Borgiel-Marek H and
Kos-Kudła B: Transforming growth factor β1 (TGF-β1) in physiology
and pathology. Endokrynol Pol. 64:384–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Barratt J and Feehally J: IgA nephropathy.
J Am Soc Nephrol. 16:2088–2097. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Coppo R and Amore A: Aberrant
glycosylation in IgA nephropathy (IgAN). Kidney Int. 65:1544–1547.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Julian BA and Novak J: IgA nephropathy: An
update. Curr Opin Nephrol Hypertens. 13:171–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lai KN: Pathogenesis of IgA nephropathy.
Nat Rev Nephrol. 8:275–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ju T, Brewer K, D'Souza A, Cummings RD and
Canfield WM: Cloning and expression of human core 1 beta1,
3-galactosyltransferase. J Biol Chem. 277:178–186. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Serino G, Sallustio F, Cox SN, Pesce F and
Schena FP: Abnormal miR-148b expression promotes aberrant
glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol.
23:814–824. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
He L, Peng Y, Liu H, Yin W, Chen X, Peng
X, Shao J, Liu Y and Liu F: Activation of the interleukin-4/signal
transducer and activator of transcription 6 signaling pathway and
homeodomain-interacting protein kinase 2 production by tonsillar
mononuclear cells in IgA nephropathy. Am J Nephrol. 38:321–332.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Inoue T, Sugiyama H, Hiki Y, Takiue K,
Morinaga H, Kitagawa M, Maeshima Y, Fukushima K, Nishizaki K, Akagi
H, et al: Differential expression of glycogenes in tonsillar B
lymphocytes in association with proteinuria and renal dysfunction
in IgA nephropathy. Clin Immunol. 136:447–455. 2010. View Article : Google Scholar : PubMed/NCBI
|
